Princeton Global Asset Management’s Immunomedics Inc IMMU Stock Holding History

Princeton Global Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-239	Closed	-$20K	–	511
2020 Q3	$20K	Hold	239	–	–	0.01%	296
2020 Q2	$8K	Hold	239	–	–	﹤0.01%	435
2020 Q1	$3K	Hold	239	–	–	﹤0.01%	453
2019 Q4	$5	Hold	239	–	–	﹤0.01%	465
2019 Q3	$4K	Hold	239	–	–	﹤0.01%	324
2019 Q2	$3K	Buy	+239	New	+$3.6K	﹤0.01%	360

Princeton Global Asset Management's IMMU Position: Q4 2020 in Review

Princeton Global Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 239 shares — an estimated $20K sold.

Princeton Global Asset Management first reported a position in IMMU in Q2 2019 and held it in 6 quarters. The position peaked at $20K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Princeton Global Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Princeton Global Asset Management sold 239 Immunomedics Inc shares in Q4 2020, an estimated $20K.
Princeton Global Asset Management first reported a position in Immunomedics Inc in Q2 2019 and held it in 6 quarters.
Princeton Global Asset Management's Immunomedics Inc position peaked at $20K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Princeton Global Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.